• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过校正计数增加值及其他公式评估血液学患者的血小板生存期

Platelet Survival in Hematology Patients Assessed by the Corrected Count Increment and Other Formulas.

作者信息

Jaime-Pérez José C, Vázquez-Hernández Karina E, Jiménez-Castillo Raúl A, Fernández Lucía T, Salazar-Riojas Rosario, Gómez-Almaguer David

机构信息

Department of Hematology, Dr José Eleuterio González University Hospital, School of Medicine of the Universidad Autónoma de Nuevo León, Monterrey, México.

出版信息

Am J Clin Pathol. 2018 Jul 31;150(3):267-272. doi: 10.1093/ajcp/aqy052.

DOI:10.1093/ajcp/aqy052
PMID:29982409
Abstract

OBJECTIVES

To compare the performance of the corrected count increment (CCI) and three other formulas to assess 24-hour posttransfusion platelet survival in hematology patients.

METHODS

Twenty-four-hour posttransfusion platelet counts were analyzed after apheresis platelet transfusion. Platelet increment (PI), percent platelet recovery (PPR), and percentage platelet increment (PPI) were compared with CCI by receiver operating characteristic analysis. Clinical factors that influence platelet survival were assessed by logistic regression.

RESULTS

In total, 142 apheresis platelet transfusions in 85 hematology patients were studied. Mean (SD) CCI at 24 hours was 11,869 (10,125). Compared with CCI, the sensitivity of other formulas ranged from 89.4% to 95.7% and specificity from 94.7% to 100%. Cutoff values were 15.7 × 103/µL for PI, 11.4% for PPR, and 17% for PPI. For ABO-compatible vs incompatible transfusions, CCI was 14,070/µL vs 9,176/µL (P = .007). Negative factors for all formulas were sepsis, hypotension, and amphotericin B.

CONCLUSIONS

PI, PPR, and PPI are comparable to CCI for assessing 24-hour platelet survival.

摘要

目的

比较校正计数增加值(CCI)和其他三个公式评估血液学患者输血后24小时血小板存活率的性能。

方法

对单采血小板输血后的输血后24小时血小板计数进行分析。通过受试者工作特征分析,将血小板增加值(PI)、血小板回收率(PPR)和血小板增加百分比(PPI)与CCI进行比较。通过逻辑回归评估影响血小板存活的临床因素。

结果

共研究了85例血液学患者的142次单采血小板输血。24小时时平均(标准差)CCI为11,869(10,125)。与CCI相比,其他公式的敏感性为89.4%至95.7%,特异性为94.7%至100%。PI的临界值为15.7×10³/µL,PPR为11.4%,PPI为17%。对于ABO血型相合与不相合输血,CCI分别为14,070/µL和9,176/µL(P = 0.007)。所有公式的负面因素为脓毒症、低血压和两性霉素B。

结论

PI、PPR和PPI在评估24小时血小板存活率方面与CCI相当。

相似文献

1
Platelet Survival in Hematology Patients Assessed by the Corrected Count Increment and Other Formulas.通过校正计数增加值及其他公式评估血液学患者的血小板生存期
Am J Clin Pathol. 2018 Jul 31;150(3):267-272. doi: 10.1093/ajcp/aqy052.
2
Determination viability of a transfused platelet product by corrected count increment and percentage platelet response.通过校正计数增加值和血小板反应百分比来确定输注血小板产品的活力。
Pan Afr Med J. 2017 Jul 28;27:226. doi: 10.11604/pamj.2017.27.226.12116. eCollection 2017.
3
Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study.非癌症患者中 ABO 相容与不相容血小板输注后血小板计数的变化:一项观察性研究。
Transfusion. 2010 Jul;50(7):1552-60. doi: 10.1111/j.1537-2995.2010.02602.x. Epub 2010 Feb 26.
4
Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.使用体外出血时间和输注血小板校正计数增加值评估血小板功能。比较来自混合白膜层和单采血小板的浓缩血小板。
Vox Sang. 1996;70(2):69-75. doi: 10.1111/j.1423-0410.1996.tb01296.x.
5
Factors influencing 20-hour increments after platelet transfusion.
Transfusion. 1991 Jun;31(5):392-6. doi: 10.1046/j.1537-2995.1991.31591263191.x.
6
Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution.校正计数增量和血小板回收率作为输血后血小板反应的指标:问题与解决方案。
Transfusion. 1999 Jun;39(6):586-92. doi: 10.1046/j.1537-2995.1999.39060586.x.
7
Efficacy of cross-match compatible platelets in multi transfused haemato-oncology patients refractory to platelet transfusion.交叉配型相合血小板对多次输血且血小板输注无效的血液肿瘤患者的疗效
Transfus Apher Sci. 2019 Dec;58(6):102657. doi: 10.1016/j.transci.2019.09.010. Epub 2019 Oct 22.
8
Comparison of efficacy of low and high dose prophylactic platelet transfusion therapy in thrombocytopenic haemato-oncology patients.低剂量与高剂量预防性血小板输注疗法对血液肿瘤血小板减少症患者疗效的比较。
Transfus Apher Sci. 2020 Feb;59(1):102610. doi: 10.1016/j.transci.2019.06.033. Epub 2019 Jul 10.
9
Evaluation of Human Leucocyte Antigen Mediated Platelet Transfusion Refractoriness and Platelet Crossmatching Assay in Patients with Hematologic Disorders.血液系统疾病患者中人类白细胞抗原介导的血小板输注无效及血小板交叉配血试验的评估
Oman Med J. 2022 Jul 31;37(4):e402. doi: 10.5001/omj.2022.81. eCollection 2022 Jul.
10
A prospective observational study to compare transfusion outcomes in ABO identical versus ABO non-identical single donor platelet concentrates: An experience from a tertiary healthcare center in India.一项前瞻性观察研究比较了 ABO 同型与 ABO 非同型单供者血小板浓缩物的输血结局:来自印度一家三级医疗中心的经验。
Transfus Clin Biol. 2022 Aug;29(3):213-218. doi: 10.1016/j.tracli.2022.05.001. Epub 2022 Jun 3.

引用本文的文献

1
First Report of MPL c.23T>G (p.M8R) Variant in Congenital Amegakaryocytic Thrombocytopenia: A Case Report.先天性无巨核细胞性血小板减少症中MPL基因c.23T>G(p.M8R)变异的首例报告:病例报告
EJHaem. 2025 Aug 28;6(5):e70136. doi: 10.1002/jha2.70136. eCollection 2025 Oct.
2
Hemostatic conditions following autologous transfusion of fresh vs stored platelets in experimental endotoxemia: an open-label randomized controlled trial with healthy volunteers.实验性内毒素血症中新鲜与储存血小板自体输血后的止血情况:一项针对健康志愿者的开放标签随机对照试验。
Res Pract Thromb Haemost. 2024 Oct 29;8(8):102612. doi: 10.1016/j.rpth.2024.102612. eCollection 2024 Nov.
3
Effect of donor parameters and cell separators on yield of apheresis platelet and their impact on corrected count increment in aplastic anemia patients.
供体参数和细胞分离器对单采血小板产量的影响及其对再生障碍性贫血患者校正计数增加值的影响。
Asian J Transfus Sci. 2023 Jul-Dec;17(2):246-250. doi: 10.4103/ajts.ajts_146_22. Epub 2023 May 11.
4
Impact of dose and storage duration of platelet concentrates on platelet recovery between ABO identical and ABO non-identical random donor platelet transfusions in hemato-oncology patients.血小板浓缩物的剂量和储存时间对血液肿瘤患者ABO血型相同和ABO血型不同的随机供体血小板输注之间血小板回收率的影响。
Hematol Transfus Cell Ther. 2024 Jul-Sep;46(3):228-236. doi: 10.1016/j.htct.2023.01.011. Epub 2023 Mar 3.
5
Prevalence, Risk Factors, and Outcomes of Platelet Transfusion Refractoriness in Critically Ill Patients: A Retrospective Cohort Study.危重症患者血小板输注无效的患病率、危险因素及结局:一项回顾性队列研究
Crit Care Res Pract. 2021 Sep 23;2021:5589768. doi: 10.1155/2021/5589768. eCollection 2021.